Sekisui Medical by Numbers

Midterm Management Plan
HIYAKU (Leap)

2020

"Global integrated management" is one of the core policies of HIYAKU. Along with the establishment of global manufacturing, marketing, development and pharmaceutical quality assurance systems, and the promotion of consolidated management of our businesses, we are aiming for net sales of 100 billion yen in FY2020.

No. of reagents we make in Japan

800products

The products we deal in include various kinds of clinical reagents, with a particular focus on the fields of blood coagulation, lifestyle related diseases, and infectious diseases. We also offer various kinds of analytical equipment, including plastic vacuum blood collection tubes and fully-automated blood coagulation analyzers that are an integral part of clinical testing.
We are expanding our lineup in each key area, and offer a comprehensive total system of diagnostic reagents and specialized analyzers.

Overseas sales ratio

45%

Established 10 years ago, we aim to become a world leading medical company. We have expanded globally, establishing business premises in North America, Europe and China, and have achieved a consolidated overseas sales ratio of 45%.

2020 API sales ratio

77%

We are shifting from amino acids to APIs as our mainstay products, and are engaged in business expansion, as well as developing a system to provide small- to medium-molecule APIs.

Japan's first non-governmental
radioisotope laboratory established

1955

We support drug development research, and non-clinical pharmacokinetic trials in particular, in a way that anticipates contemporary needs. In recent years, we carried out Japan's first clinical pharmacokinetic trial utilizing radioisotopes. We provide support to help with the acquisition of Proof of Concept that verifies a drug's effectiveness and safety for humans at an early stage.

Health and
Productivity Management 500

500

We implement health management based upon the approach that "our employees are valuable assets entrusted to us by the wider community".
We have been accredited by the FY2020 Certified Health & Productivity Management Organization Recognition Program run by the Ministry of Economy, Trade and Industry and Nippon Kenko Kaigi for three consecutive years.
Going forward, we will continue to help our employees to autonomously manage their own health, and we will contribute to society via our business.